Updated Jul 16, 2026
Lane Benjamin has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Lane Benjamin is associated with Nuvalent, Inc., a biotechnology company focused on developing targeted therapies for cancer. Further details about his role and contributions to the company are not widely documented in public sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | NUVL | Nuvalent, Inc. | D — Derivative transaction | 7.1K | — | |
| 2026-07-15 | NUVL | Nuvalent, Inc. | A — Grant or award | 7.1K | $0.00 | |
| 2026-07-15 | NUVL | Nuvalent, Inc. | D — Derivative transaction | 29.4K | — | |
| 2026-07-15 | NUVL | Nuvalent, Inc. | J — Other acquisition / disposition | 21.1K | $124.00 | $2.62M |
| 2026-04-02 | NUVL | Nuvalent, Inc. | A — Grant or award | 9.5K | $0.00 |
Lane Benjamin is associated with Nuvalent, Inc., a biotechnology company focused on developing targeted therapies for cancer. Further details about his role and contributions to the company are not widely documented in public sources.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lane Benjamin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.